Consultant Haematologist with special interest in Myeloid disorders
| Dyddiad hysbysebu: | 28 Mai 2025 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £105,504 - £139,882 Per annum |
| Oriau: | Rhan Amser |
| Dyddiad cau: | 27 Mehefin 2025 |
| Lleoliad: | Bournemouth, BH7 7DW |
| Cwmni: | Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | 7185370/153-M3669 |
Crynodeb
A Vacancy at University Hospitals Dorset NHS Foundation Trust.
With a multi-million-pound investment, UHD is a recently formed 1000 bed Trust comprised of Poole Hospital, Royal Bournemouth & Christchurch Hospitals in partnership with Bournemouth University. The 30-bed haematology in-patient unit, including the established JACIE accredited autologous transplant unit will be housed at the Royal Bournemouth Hospital (major acute & emergency hospital) from April 2024 which also has day case chemotherapy and outpatient facilities. Poole Hospital is being developed as the major planned/elective care hospital and will have day case chemotherapy and outpatient facilities.
We currently run dedicated CLL, lymphoma, WM, myeloma, MDS & MPN clinics. We have representation on the NCRI MDS, MPN, Myeloma & CLL subgroups, and UK Myeloma society, UK CLL forum and UK MDS forum executive committees and are actively involved in writing BSH national guidelines.
We are recruiting to a Haemato-oncology consultant posts (10PA) as below:
Consultant with a specialist interest in myeloid diseases
Applicants with other sub-speciality interests and wishing to work LTFT will also be considered.
The successful candidates will join our friendly team of haemato-oncology consultants and participate in a 1:13 rota supported by a 2 tiered SHO and SpR junior doctor on call rotas.
We have an active JACIE accredited transplant centre for Dorset autologous stem cell transplants and we network with the university hospitals Southampton transplant team who provide the allogeneic & CART-cell service for our patients.
At UHD we are proud of the service we offer our patients including access to an extensive clinical trial portfolio and novel treatment delivery approaches with a strong home care & community chemotherapy team. We intend to expand our service and would welcome candidates interested in further developing our bispecific antibody programme. We expect all colleagues to take an active role in clinical research and encourage consultants to take on local PI & CI roles in their sub-speciality interest.
We have strong links with Southampton & Bournemouth universities and there is the opportunity of collaborative research. We currently have 1 PhD student based in the Dorset Pathology Hub which has recently opened on the Bournemouth site & houses the Dorset HMDS.
We do reserve the right to close this advertisement early if we receive a high volume of suitable applications.
Our values define who we are as #TeamUHD. They underpin everything we do now and in the future. They define how we treat our patients, visitors, and each other, our valued teammates and colleagues.
UHD are investing in services across the Trust, with many being transformed and developed following merger and the New Hospital Programme.
This means that some services may move site this year or next, either temporarily or long term. Recruiting Managers interviewing for this role will be happy to answer any specific questions that you have at interview.
For further details relating to the job description and main responsibilities, please refer to the attached documents.
We need someone to start ASAP.
This advert closes on Wednesday 25 Jun 2025
With a multi-million-pound investment, UHD is a recently formed 1000 bed Trust comprised of Poole Hospital, Royal Bournemouth & Christchurch Hospitals in partnership with Bournemouth University. The 30-bed haematology in-patient unit, including the established JACIE accredited autologous transplant unit will be housed at the Royal Bournemouth Hospital (major acute & emergency hospital) from April 2024 which also has day case chemotherapy and outpatient facilities. Poole Hospital is being developed as the major planned/elective care hospital and will have day case chemotherapy and outpatient facilities.
We currently run dedicated CLL, lymphoma, WM, myeloma, MDS & MPN clinics. We have representation on the NCRI MDS, MPN, Myeloma & CLL subgroups, and UK Myeloma society, UK CLL forum and UK MDS forum executive committees and are actively involved in writing BSH national guidelines.
We are recruiting to a Haemato-oncology consultant posts (10PA) as below:
Consultant with a specialist interest in myeloid diseases
Applicants with other sub-speciality interests and wishing to work LTFT will also be considered.
The successful candidates will join our friendly team of haemato-oncology consultants and participate in a 1:13 rota supported by a 2 tiered SHO and SpR junior doctor on call rotas.
We have an active JACIE accredited transplant centre for Dorset autologous stem cell transplants and we network with the university hospitals Southampton transplant team who provide the allogeneic & CART-cell service for our patients.
At UHD we are proud of the service we offer our patients including access to an extensive clinical trial portfolio and novel treatment delivery approaches with a strong home care & community chemotherapy team. We intend to expand our service and would welcome candidates interested in further developing our bispecific antibody programme. We expect all colleagues to take an active role in clinical research and encourage consultants to take on local PI & CI roles in their sub-speciality interest.
We have strong links with Southampton & Bournemouth universities and there is the opportunity of collaborative research. We currently have 1 PhD student based in the Dorset Pathology Hub which has recently opened on the Bournemouth site & houses the Dorset HMDS.
We do reserve the right to close this advertisement early if we receive a high volume of suitable applications.
Our values define who we are as #TeamUHD. They underpin everything we do now and in the future. They define how we treat our patients, visitors, and each other, our valued teammates and colleagues.
UHD are investing in services across the Trust, with many being transformed and developed following merger and the New Hospital Programme.
This means that some services may move site this year or next, either temporarily or long term. Recruiting Managers interviewing for this role will be happy to answer any specific questions that you have at interview.
For further details relating to the job description and main responsibilities, please refer to the attached documents.
We need someone to start ASAP.
This advert closes on Wednesday 25 Jun 2025
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.